Advanced Viral Research CP (ADVR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Viral Research CP (ADVR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shawn Murphy who wrote (2223)	3/7/1997 9:00:00 PM
From: garden_man	of 2281

To All, With so many emails I have received lately, I had to come back only briefly. I must post this news for all investors and shorters of this stock. I will not debate any more on this thread with the naysayers. Please folks who are "invested" in ADVR, keep the faith! Thanks for time and consideration! The Wall Street Journal Interactive Edition -- March 7, 1997 Corrections & Amplifications PETER GEORGESCU was named chief executive officer of Young & Rubicam Inc. in 1993 and chairman in 1994. Monday's Advertising column incorrectly stated his title and the dates he assumed these positions. ADVANCED VIRAL RESEARCH Corp. says it wasn't the source of a payment to George Chelekis, whom the Securities and Exchange Commission said was paid for recommending its stock on his on-line newsletter. Another of the companies whose stock was involved in the case, Quest International Resources Corp., says it has no reason to believe that it is under investigation by the SEC. The companies were mentioned in a Feb. 26 article on the settlement of an SEC lawsuit against Mr. Chelekis.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next